open access
메뉴
open access
메뉴
ISSN : 0376-4672
Burning mouth syndrome(BMS) is a burning sensation in the oral mucosa and doesn°Øt have any identifiable oral lesion and organic etiology. Diagnosis of BMS is mainly based on clinical features and serial exclusion of other possible causes. There is no specific examination for BMS and that could embarrasse the dentist. In this study, the characteristics, differential diagnosis and several treatments of BMS are presented so that dentists can better diagnose BMS to maintain a good relationship with the patients.
1. McMillan R, Forssell H, Buchanan JA, Glenny AM, Weldon JC, Zakrzewska JM. Interventions for treating burning mouth syndrome. Cochrane Database Syst Rev 2016; 11:CD002779.
2. Anonymous구강 작열감 증후군 ( BMS ) 의 임상적 특징 및 치료에 관한 연구 ( A study on the clinical characteristics and treatment in burning mouth syndrome ). 1995; 20:39-52.
3. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. Am Fam Physician 2002; 65:615-620.
4. Lamey PJ, Hobson RS, Orchardson R. Perception of stimulus size in patients with burning mouth syndrome. J Oral Pathol Med 1996; 25:420-423.
5. Woda A, Dao T, Gremeau-Richard C. Steroid dysregulation and stomatodynia (burning mouth syndrome). J Orofac Pain 2009; 23:202-210.
6. Forssell H, Jaaskelainen S, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002; 99:41-47.
7. Gao S, Wang Y, Wang Z. Assessment of trigeminal somatosensory evoked potentials in burning mouth syndrome. Chin J Dent Res 2000; 3:40-46.
8. Jaaskelainen SK, Rinne JO, Forssell H et al. Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study. Pain 2001; 90:257-260.
9. Albuquerque RJ, de Leeuw R, Carlson CR, Okeson JP, Miller CS, Andersen AH. Cerebral activation during thermal stimulation of patients who have burning mouth disorder: An fMRI study. Pain 2006; 122:223-234.
10. Jaaskelainen SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol 2012; 123:71-77.
11. Liu YF, Kim Y, Yoo T, Han P, Inman JC. Burning mouth syndrome: A systematic review of treatments. Oral Dis 2017.
12. Lauria G, Majorana A, Borgna M et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005; 115:332-337.
13. Yilmaz Z, Renton T, Yiangou Y et al. Burning mouth syndrome as a trigeminal small fibre neuropathy: Increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J Clin Neurosci 2007; 14:864-871.
14. Grushka M, Epstein JB, Gorsky M. Burning mouth syndrome. Am Fam Physician 2002; 65:615-620.
15. Bartoshuk LM, Snyder DJ, Grushka M, Berger AM, Duffy VB, Kveton JF. Taste damage: Previously unsuspected consequences. Chem Senses 2005; 30Suppl 1:i218-9.
16. Eliav E, Kamran B, Schaham R, Czerninski R, Gracely RH, Benoliel R. Evidence of chorda tympani dysfunction in patients with burning mouth syndrome. J Am Dent Assoc 2007; 138:628-633.
17. Baliki MN, Mansour AR, Baria AT, Apkarian AV. Functional reorganization of the default mode network across chronic pain conditions. PLoS One 2014; 9:e106133.
18. Kolkka-Palomaa M, Jaaskelainen SK, Laine MA, Teerijoki-Oksa T, Sandell M, Forssell H. Pathophysiology of primary burning mouth syndrome with special focus on taste dysfunction:A review. Oral Dis 2015; 21:937-948.
19. Hagelberg N, Forssell H, Rinne JO et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 2003; 101:149-154.
20. Lambert G, Johansson M, Agren H, Friberg P. Reduced brain norepinephrine and dopamine release in treatment-refractory depressive illness:Evidence in support of the catecholamine hypothesis of mood disorders. Arch Gen Psychiatry 2000; 57:787-793.
21. Moraga-Amaro R, Gonzalez H, Pacheco R, Stehberg J. Dopamine receptor D3 deficiency results in chronic depression and anxiety. Behav Brain Res 2014; 274:186-193.
22. Lamey PJ, Murray BM, Eddie SA, Freeman RE. The secretion of parotid saliva as stimulated by 10% citric acid is not related to precipitating factors in burning mouth syndrome. J Oral Pathol Med 2001; 30:121-124.
23. Hershkovich O, Nagler RM. Biochemical analysis of saliva and taste acuity evaluation in patients with burning mouth syndrome, xerostomia and/or gustatory disturbances. Arch Oral Biol 2004; 49:515-522.
24. Granot M, Nagler RM. Association between regional idiopathic neuropathy and salivary involvement as the possible mechanism for oral sensory complaints. J Pain 2005; 6:581-587.
25. Morr Verenzuela CS, Davis MDP, Bruce AJ, Torgerson RR. Burning mouth syndrome: Results of screening tests for vitamin and mineral deficiencies, thyroid hormone, and glucose levelsexperience at mayo clinic over a decade. Int J Dermatol 2017.
26. Gremeau-Richard C, Woda A, Navez ML et al. Topical clonazepam in stomatodynia: A randomised placebo-controlled study. Pain 2004; 108:51-57.
27. Rodriguez de Rivera Campillo E, Lopez-Lopez J, Chimenos-Kustner E. Response to topical clonazepam in patients with burning mouth syndrome: A clinical study. Bull Group Int Rech Sci Stomatol Odontol 2010; 49:19-29.
28. Heckmann SM, Kirchner E, Grushka M, Wichmann MG, Hummel T. A double-blind study on clonazepam in patients with burning mouth syndrome. Laryngoscope 2012; 122:813-816.
29. Bergdahl J, Anneroth G, Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: A controlled study. J Oral Pathol Med 1995; 24:213-215.
30. Femiano F, Gombos F, Scully C. Burning mouth syndrome: Open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy. Med Oral 2004; 9:8-13.
31. Miziara ID, Filho BC, Oliveira R, Rodrigues dos Santos RM. Group psychotherapy: An additional approach to burning mouth syndrome. J Psychosom Res 2009; 67:443-448.
32. Carbone M, Pentenero M, Carrozzo M, Ippolito A, Gandolfo S. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: A double-blind, randomized, placebo-controlled study. Eur J Pain 2009; 13:492-496.
33. Lopez-D'alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of burning mouth syndrome: A randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal 2011; 16:e635-40.
34. Cavalcanti DR, da Silveira FR. Alpha lipoic acid in burning mouth syndrome--a randomized doubleblind placebo-controlled trial. J Oral Pathol Med 2009; 38:254-261.
35. Lopez-Jornet P, Camacho-Alonso F, Leon-Espinosa S. Efficacy of alpha lipoic acid in burning mouth syndrome: A randomized, placebo-treatment study. J Oral Rehabil 2009; 36:52-57.
36. Femiano F, Gombos F, Scully C, Busciolano M, De Luca P. Burning mouth syndrome (BMS):Controlled open trial of the efficacy of alpha-lipoic acid (thioctic acid) on symptomatology. Oral Dis 2000; 6:274-277.
37. Palacios-Sanchez B, Moreno-Lopez LA, Cerero-Lapiedra R, Llamas-Martinez S, Esparza-Gomez G. Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial. Med Oral Patol Oral Cir Bucal 2015; 20:e435-40.
38. Femiano F, Scully C. Burning mouth syndrome (BMS): Double blind controlled study of alphalipoic acid (thioctic acid) therapy. J Oral Pathol Med 2002; 31:267-269.
39. Silvestre FJ, Silvestre-Rangil J, Tamarit-Santafe C, Bautista D. Application of a capsaicin rinse in the treatment of burning mouth syndrome. Med Oral Patol Oral Cir Bucal 2012; 17:e1-4.
40. Petruzzi M, Lauritano D, De Benedittis M, Baldoni M, Serpico R. Systemic capsaicin for burning mouth syndrome: Short-term results of a pilot study. J Oral Pathol Med 2004; 33:111-114.
41. Tammiala-Salonen T, Forssell H. Trazodone in burning mouth pain: A placebo-controlled, doubleblind study. J Orofac Pain 1999; 13:83-88.
42. Cano-Carrillo P, Pons-Fuster A, Lopez-Jornet P. Efficacy of lycopene-enriched virgin olive oil for treating burning mouth syndrome: A double-blind randomised. J Oral Rehabil 2014; 41:296-305.
43. Sardella A, Lodi G, Demarosi F, Tarozzi M, Canegallo L, Carrassi A. Hypericum perforatum extract in burning mouth syndrome: A randomized placebo-controlled study. J Oral Pathol Med 2008; 37:395-401.
44. Silva LA, Siqueira JT, Teixeira MJ, Siqueira SR. The role of xerostomia in burning mouth syndrome: A case-control study. Arq Neuropsiquiatr 2014; 72:91-98.
45. Spanemberg JC, Cherubini K, de Figueiredo MA, Gomes AP, Campos MM, Salum FG. Effect of an herbal compound for treatment of burning mouth syndrome: Randomized, controlled, double-blind clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol 2012; 113:373-377.
46. Treldal C, Jacobsen CB, Mogensen S et al. Effect of a local anesthetic lozenge in relief of symptoms in burning mouth syndrome. Oral Dis 2016; 22:123-131.
47. Patton LL, Siegel MA, Benoliel R, De Laat A. Management of burning mouth syndrome:Systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 103 Suppl:S39.e1-13.